Antonio Vidal‐Puig

This study identifies miR-10b-5p as a regulator of adipocyte differentiation by targeting Gata6 and Tubby, with distinct effects on white and brown adipogenesis.

This study identifies TGM2 as a predictive marker of hepatic steatosis improvement in obese mice infected with H. p. bakeri, showing its role in type 2 immune responses and potential therapeutic applications.

Alox15-deficient mice heal skin punch wounds with excess collagen, low matrix metalloproteinase activity and unresolved inflammatory gene expression; topical physiological 12/15-lipoxygenase oxylipin mixtures reduced collagen and raised collagenase activity.

This study shows that mice adjust their behavior and metabolism in response to protein restriction, with temperature affecting amino acid homeostasis and metabolic adaptations.

This paper develops a molecular trajectory-based framework to model MASLD progression using transcriptomic and proteomic data, identifying novel biomarkers and mechanistic insights.

This study identifies mesenchymal Igf2 as a critical paracrine regulator of pancreatic growth and function through in vivo and ex vivo experiments.

The paper identifies conserved amino acid residues in prolidase across species and links them to functional importance and pathogenic potential in human disease.

This study creates a mouse model of SHORT syndrome by introducing a Pik3r1 mutation, revealing lipodystrophic insulin resistance without dyslipidemia.